Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rivaroxaban versus warfarin after venous stent implantation in post-thrombotic syndrome
ChiCTR1800020395Phase 4Not yet recruiting
- Sponsor
- Shanghai Ninth People's Hospital
- Start
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of rivaroxaban and warfarin in post-thrombotic syndrome (PTS) (2 arms), sponsored by Shanghai Ninth People's Hospital. Primary endpoint: Stent patency. Planned start Jan 2019; status: not yet recruiting.
02
Drugs
rivaroxabanwarfarin
03
Conditions
post-thrombotic syndrome (PTS)
Beyond the preview
Go deeper on ChiCTR1800020395.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800020395.